BusinesseFFECTOR Announces Appointment of John W. Smither to its Board of DirectorsBy Nasdaq OMXMar 23, 2018, 6:00 PM UTC
BusinessPrecipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy PlatformBy Nasdaq OMXMar 20, 2018, 11:37 AM UTC
BusinessAdaptimmune Announces Responses in Second Solid Tumor Indication with NY-ESO SPEAR T-cellsBy Nasdaq OMXMar 15, 2018, 11:30 AM UTC
BusinessCrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology AgentsBy Nasdaq OMXMar 13, 2018, 12:00 PM UTC
BusinessImmune Design Reports Data Update for Lead Immunotherapy Programs: Improvement in Survival for CMB305 Monotherapy in Sarcoma and Increased Objective Responses for G100/pembrolizumab Combination in Follicular LymphomaBy Nasdaq OMXMar 12, 2018, 12:01 PM UTC
BusinessCrown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel ImmunotherapiesBy Nasdaq OMXMar 9, 2018, 1:02 PM UTC
BusinessTRANSWESTERN RAISES OVER $166,000 IN 12 MONTHS TO SUPPORT NATIONAL PHILANTHROPY PARTNER, MAKE-A-WISH®By Nasdaq OMXMar 8, 2018, 5:27 PM UTC
BusinessAptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM OncologyBy Nasdaq OMXMar 7, 2018, 12:00 PM UTC
